Supported by its exclusive strategic & financial advisor, Remora Partners, the French medical device company Infinite Vision Optics, which develops innovative adjustable intraocular lenses for cataract and refractive surgery, announces that it has raised capital funding of EUR 550’000. Remora Capital, a holding company exclusively active in the healthcare, beauty care and nutrition industries, managed by Remora Partners, led the round which was completed by Alsace Business Angels and private investors. In addition, the French “Banque Publique d’Investissement”, through Alsace bpifrance, provides support through its “Aide au Développement Innovation” program.
Nicolas Kern, from Alsace Business Angels comments: “The experience and market focus of the team convinced us to support the company. The success of the funding round also demonstrates the attractiveness of the Alsace region for high-tech medical technologies.”
The funds obtained will allow the company to advance its adjustable intraocular lens product through regulatory pathway towards CE marking and establish ISO compliant manufacturing. Concomitant to the capital increase, Infinite Vision Optics announces the nomination of Dr. Carsten LAUE, principal at Remora Partners, as CEO of the company. Dr. Carsten Laue, former CEO of a Swiss CRO and Researcher at IMD Business School adds extensive experience in CE-marking of medical devices and clinical development to the management team. The former CEO, Dr. Hans OTT, will remain President and take over the position as CSO of the company.
About Infinite Vision Optics SAS
Founded November 2010, Infinite Vision Optics (IVO) has developed the intraocular lens docking station that allows the adjustment of the IVO intraocular lens throughout the patient’s life when needed. A full lens explantation is replaced by a simple and minimally invasive secondary procedure. This proprietary docking station system provides surgeons a solution to achieve the best possible refractive outcome by substantially reducing the risk associated with full lens explantation as well as providing the patient with solutions to refractive and medical changes throughout their lifetime that cannot be predicted at the time of the initial cataract procedure. The company is based in Strasbourg, France and has received the label “Entreprise Innovante des Pôles” in October 2012.
About Remora Partners SA
Remora Partners, Lausanne, Switzerland, is an investment and advisory firm specialized in the healthcare, beauty care, and nutrition industries. Thanks to its industrial and financial expertise, Remora Partners provides hands-on and sustainable support to innovative companies in Switzerland and surrounding countries. Remora Partners currently manages a portfolio of 7 partcipations, held by Remora Capital, its investment arm.
Contact:
Infinite Vision Optics SAS
4, rue de Sarrelouis
F-67000 Strasbourg
T +33 3 88 10 04 10
www.infinitevisionoptics.com
Remora Partners SA
rue du Petit Chêne 12
CH-1003 Lausanne
T +41 21 311 03 76
www.remora-partners.ch